AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
Erlotinib Hydrochloride in Rwanda
2 products registered with RDA — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ERLOCIP 150 TABLETS | Rwanda FDA-HMP-MA-1633 | CIPLA LTD | active | 16 Aug 2029 |
| ERLOCIP 100 TABLETS | Rwanda FDA-HMP-MA-1662 | CIPLA LTD | active | 15 Aug 2029 |
Erlotinib Hydrochloride — RDA Registration Details
RDA (Rwanda) has 2 registered products containing Erlotinib Hydrochloride, of which 2 are currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track Erlotinib Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.